CA2186526A1 - Procede et produit de regulation de la sensibilite des cellules a des signaux externes - Google Patents

Procede et produit de regulation de la sensibilite des cellules a des signaux externes

Info

Publication number: CA2186526A1
Authority: CA; Canada
Prior art keywords: proteins; present; product; external signals; encode
Prior art date: 1994-04-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

CA2186526A

Other languages

English (en)

Other versions

CA2186526C (fr

Inventor

Gary L. Johnson

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

National Jewish Health

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-04-15

Filing date

1994-10-14

Publication date

1995-10-26

1994-04-15 Priority claimed from PCT/US1994/004178 external-priority patent/WO1994024159A1/fr

1994-10-14 Application filed by Individual filed Critical Individual

1994-10-14 Priority claimed from PCT/US1994/011690 external-priority patent/WO1995028421A1/fr

1995-10-26 Publication of CA2186526A1 publication Critical patent/CA2186526A1/fr

1999-12-14 Application granted granted Critical

1999-12-14 Publication of CA2186526C publication Critical patent/CA2186526C/fr

2014-10-14 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

238000000034 method Methods 0.000 title abstract 2
230000001105 regulatory effect Effects 0.000 title 1
230000004043 responsiveness Effects 0.000 title 1
102000004169 proteins and genes Human genes 0.000 abstract 5
108090000623 proteins and genes Proteins 0.000 abstract 5
102000001291 MAP Kinase Kinase Kinase Human genes 0.000 abstract 2
108060006687 MAP kinase kinase kinase Proteins 0.000 abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
102000039446 nucleic acids Human genes 0.000 abstract 2
108020004707 nucleic acids Proteins 0.000 abstract 2
150000007523 nucleic acids Chemical class 0.000 abstract 2
208000023275 Autoimmune disease Diseases 0.000 abstract 1
102100031480 Dual specificity mitogen-activated protein kinase kinase 1 Human genes 0.000 abstract 1
101710146526 Dual specificity mitogen-activated protein kinase kinase 1 Proteins 0.000 abstract 1
102100023266 Dual specificity mitogen-activated protein kinase kinase 2 Human genes 0.000 abstract 1
101710146529 Dual specificity mitogen-activated protein kinase kinase 2 Proteins 0.000 abstract 1
206010020751 Hypersensitivity Diseases 0.000 abstract 1
206010061218 Inflammation Diseases 0.000 abstract 1
241001465754 Metazoa Species 0.000 abstract 1
102000004232 Mitogen-Activated Protein Kinase Kinases Human genes 0.000 abstract 1
108090000744 Mitogen-Activated Protein Kinase Kinases Proteins 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
208000012902 Nervous system disease Diseases 0.000 abstract 1
208000025966 Neurological disease Diseases 0.000 abstract 1
201000011510 cancer Diseases 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000035475 disorder Diseases 0.000 abstract 1
229940088597 hormone Drugs 0.000 abstract 1
239000005556 hormone Substances 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
230000019491 signal transduction Effects 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Landscapes

Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Enzymes And Modification Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Container Filling Or Packaging Operations (AREA)

CA002186526A 1994-04-15 1994-10-14 Procede et produit de regulation de la sensibilite des cellules a des signaux externes Expired - Fee Related CA2186526C (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
WOPCT/US94/04178		1994-04-15
PCT/US1994/004178 WO1994024159A1 (fr)	1993-04-15	1994-04-15	Procede et produit de regulation de la reactivite cellulaire a des signaux externes
PCT/US1994/011690 WO1995028421A1 (fr)	1993-04-15	1994-10-14	Procede et produit de regulation de la sensibilite des cellules a des signaux externes

Publications (2)

Publication Number	Publication Date
CA2186526A1 true CA2186526A1 (fr)	1995-10-26
CA2186526C CA2186526C (fr)	1999-12-14

Family

ID=22242467

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002186526A Expired - Fee Related CA2186526C (fr)	1994-04-15	1994-10-14	Procede et produit de regulation de la sensibilite des cellules a des signaux externes

Country Status (5)

Country	Link
JP (2)	JP3980635B2 (fr)
AT (1)	ATE319821T1 (fr)
AU (1)	AU703070B2 (fr)
CA (1)	CA2186526C (fr)
DE (1)	DE69434650T2 (fr)

1994
- 1994-10-14 JP JP52693995A patent/JP3980635B2/ja not_active Expired - Lifetime
- 1994-10-14 AU AU80177/94A patent/AU703070B2/en not_active Ceased
- 1994-10-14 DE DE69434650T patent/DE69434650T2/de not_active Expired - Fee Related
- 1994-10-14 AT AT94931372T patent/ATE319821T1/de not_active IP Right Cessation
- 1994-10-14 CA CA002186526A patent/CA2186526C/fr not_active Expired - Fee Related
2005
- 2005-07-25 JP JP2005215113A patent/JP3980609B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JP2006051026A (ja)	2006-02-23
ATE319821T1 (de)	2006-03-15
DE69434650D1 (de)	2006-05-04
AU8017794A (en)	1995-11-10
CA2186526C (fr)	1999-12-14
JPH09511906A (ja)	1997-12-02
AU703070B2 (en)	1999-03-11
JP3980609B2 (ja)	2007-09-26
JP3980635B2 (ja)	2007-09-26
DE69434650T2 (de)	2006-11-09

Similar Documents

Publication	Publication Date	Title
EP0278776A3 (fr)	1989-09-13	Méthodes et acide desoxyribonucléique pour la préparation de la protéine du facteur tissulaire
WO1998007850A3 (fr)	1998-09-17	Agents pour la detection pre-symptomatique et le ciblage therapeutique de la maladie d'alzheimer et du syndrome de down chez l'homme
WO1998019167A3 (fr)	1998-09-03	Gene de classe i du complexe majeur d'histocompatibilite humain a stress cellulaire regule
CA2257133A1 (fr)	1997-12-18	Variantes hyperactives de la desoxyribonuclease i humaine
AU6974996A (en)	1997-05-15	Compositions for the treatment of dermatological disorders and methods for their use
AU9693998A (en)	1999-05-03	Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system
CA2068027A1 (fr)	1992-11-08	Compositions pharmaceutiques comprenant une anticytokine
WO2001070977A3 (fr)	2002-03-28	Molecules analogues au recepteur du facteur de croissance du fibroblaste, et leurs utilisations
WO1994020062A3 (fr)	1996-08-15	Balanoides utilisables comme inhibiteurs de la proteine kinase c
BG105012A (en)	2001-08-31	N-linked sulphonamides of n-heterocyclic carboxylic acids or carboxylic isosteres
WO2003089575A3 (fr)	2004-10-07	Anticorps se liant specifiquement au tl5
WO2002004610A3 (fr)	2002-07-11	Regulation d'une enzyme humaine du type dipeptidyl-peptidase iv
WO2002028906A3 (fr)	2002-11-14	Regulation d'une proteine humaine de type sphingosine kinase
EP0181634A3 (fr)	1987-09-09	Gène synthétique pour lysozyme humaine
EP0744408A3 (fr)	1997-01-02	Protéine d'ob et son ADN
WO2001060990A3 (fr)	2002-03-21	Nouvelles kinases de sphingosine
WO2001042474A3 (fr)	2002-02-28	Molecules de type interferon et utilisations
WO1999028464A3 (fr)	1999-11-11	Adn complementaires et proteines appartenant a la superfamille bhlh-pas des regulateurs de transcription et procedes d'utilisation correspondants
WO2001031008A3 (fr)	2002-03-07	Gene fgf-20 humain et produits d'expression genique
WO1999062879A8 (fr)	2000-05-04	Urees et carbamates d'acides carboxyliques n-heterocycliques et d'isosteres d'acide carboxylique
WO2001020026A3 (fr)	2001-12-13	Polymorphismes du gene humain hpxr et leur utilisation dans des applications diagnostiques et therapeutiques
HK142093A (en)	1994-01-07	Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it
DE19681032D2 (de)	1999-04-08	Gentherapeutisches Nukleinsäurekonstrukt, seine Herstellung und Verwendung zur Behandlung von Herzerkrankungen
WO2001055410A3 (fr)	2002-03-14	Compositions de ceramidase et procedes fondes sur ces dernieres
WO1994024279A3 (fr)	1995-03-30	Agents pour la prevention et le traitement de la choree de huntington et d'autres troubles neurologiques

Legal Events

Date	Code	Title	Description
1996-09-25	EEER	Examination request
2009-10-14	MKLA	Lapsed